A recent proposal from the Trump administration to keep Medicare Advantage payment rates nearly flat for 2027 has sent shockwaves through the health insurance sector. Major players like UnitedHealth, Humana, and CVS have experienced significant stock declines, with shares plummeting by as much as 12% in after-hours trading. The proposed 0.09% increase in Medicare Advantage payments has been deemed insufficient by market analysts, triggering a widespread sell-off in healthcare stocks. Investors are reacting to concerns that steadier rates will negatively impact profitability, as highlighted by reports of sharp declines in insurers’ stock prices. The announcement has sparked volatility in the stock market and may have implications for future earnings forecasts within the healthcare industry.